Resource Library

Tech tools help Digital Therapeutics (DTx) maximize the impact of the real-world data they capture, explore how in this blog from Castor

In this guide, Castor discusses routes to digital therapeutics commercialization and tools to meet the challenges on the path to market

The regulations around digital therapeutics (DTx) are constantly changing. Learn how DTx providers are trying to overcome these challenges

Designed for decentralized, hybrid, and traditional research projects, Castor’s eConsent solution delivers compliant, site-friendly & participant-centric trial onboarding experiences.

Digital Therapeutics (DTx) is a rapidly growing space whose players are facing challenges in scaling their businesses, including testing. Learn more about growing successfully.

Cybersecurity has become a concern for Digital Therapeutics (DTx) developers and regulatory bodies. Learn to balance functionality & security.

Castor announced transformative growth with anticipated topline acceleration driven by the company’s momentous US market expansion

CB Insights named Castor to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world.

Castor advisor Craig Lipset, suggests that you consider DCT technology as three separate tiers. Learn more about these tiers and get started with DCT in 2022 with these pro tips.

Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications. This article explores current regulations for various classes of medical devices and how this will impact the need for participants to visit research sites throughout the trial.